Physician profile
Jacqueline Eubany
NPI 1912986944
$38,743.60
in general payments reported to CMS, 2019-2025
20 companies · $7,336 in 2025
The $7,336 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $4,095 · 2021: $5,309 · 2022: $1,859 · 2023: $2,605 · 2024: $977 · 2025: $7,336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,500 · Food and Beverage: $3,121 · Travel and Lodging: $2,621 · Consulting Fee: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,500.00 |
| Food and Beverage | $3,121.34 |
| Travel and Lodging | $2,621.14 |
| Consulting Fee | $675.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $12,731.07 | 2019-2025 | Solia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $6,876.90 | 2019-2025 | Lifevest |
| Biosense Webster, INC. | $5,286.48 | 2019-2024 | Carto 3 |
| Abbott Laboratories | $4,608.43 | 2019-2024 | Ensite Precision, Ensite, Aveir |
| Medtronic, INC. | $4,297.24 | 2021-2025 | Affera Mapping System |
| Medtronic Vascular, INC. | $3,033.55 | 2019-2020 | |
| Boston Scientific Corporation | $544.11 | 2019-2024 | |
| Cardiofocus, INC. | $331.88 | 2023 | Heartlight System |
| Novartis Pharmaceuticals Corporation | $208.81 | 2020-2023 | |
| Janssen Pharmaceuticals, INC | $168.59 | 2019-2023 | Xarelto |
| Acutus Medical, INC. | $123.31 | 2023 | |
| Pfizer INC. | $111.51 | 2019 | |
| Merck Sharp & Dohme LLC | $94.48 | 2022-2025 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $87.77 | 2019-2022 | |
| Kestra Medical Technology Services, INC. | $64.25 | 2022-2024 | Assure Wcd |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $48.51 | 2022-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Abiomed | $35.97 | 2025 | |
| Alnylam Pharmaceuticals INC. | $35.30 | 2025 | Amvuttra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.65 | 2025 | Jardiance |
| Lantheus Medical Imaging, INC. | $25.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Eubany listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.